Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins.

Karimi N, Cvjetkovic A, Jang SC, Crescitelli R, Hosseinpour Feizi MA, Nieuwland R, Lötvall J, Lässer C. · 2018

Read Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins. by Karimi N, Cvjetkovic A, Jang SC, Crescitelli R, Hosseinpour Feizi MA, Nieuwland R, Lötvall J, Lässer C. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6021463.txt.

Introduction

Karimi and co-authors present a cleaner way to isolate extracellular vesicles from blood. Their methods study appeared in Cellular and Molecular Life Sciences. Vesicles are tiny membrane sacs that cells release. Blood also carries lipoproteins, which are close in size. That overlap makes pure vesicle samples hard to obtain.

Size-based separation alone left lipoproteins mixed in. Adding a density cushion cut that contamination about a hundred-fold. With the cleaner samples, the team identified 1,187 proteins by mass spectrometry. Several had never been reported in plasma vesicle studies before. Readers get a tested protocol for biomarker work. It shows blood can serve as a real source of vesicle markers.

Catalog record

CREATORKarimi N, Cvjetkovic A, Jang SC, Crescitelli R, Hosseinpour Feizi MA, Nieuwland R, Lötvall J, Lässer C.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE55 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6021463

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins By Nasibeh Karimi, Aleksander Cvjetkovic, Su Chul Jang, Rossella Crescitelli, Mohammad Ali Hosseinpour Feizi, Rienk Nieuwland, Jan Lötvall, Cecilia Lässer Published in: Cellular and Molecular Life Sciences: CMLS DOI: 10.1007/s00018-018-2773-4 ABSTRACT The isolation of extracellular vesicles (EVs) from blood is of great importance to understand the biological role of circulating EVs and to develop EVs as biomarkers of disease. Due to the concurrent presence of lipoprotein particles, however, blood is one of the most difficult body fluids to isolate EVs from. The aim of this study was to develop a robust method to isolate and characterise EVs from blood with minimal contamination by plasma proteins and lipoprotein particles. Plasma and serum were collected from healthy subjects, and EVs were isolated by size-exclusion chromatography (SEC), with most particles being present in fractions 8–12, while the bulk of the plasma proteins was present in fractions 11–28. Vesicle markers peaked in fractions 7–11; however, the same fractions also contained lipoprotein particles. The purity of EVs was improved by combining a density cushion with SEC to further separate lipoprotein particles from the vesicles, which reduced the contamination of lipoprotein particles by 100-fold. Using this novel isolation procedure, a total of 1187 proteins were identified in plasma EVs by mass spectrometry, of which several proteins are known as EV-associated proteins but have hitherto not been identified in the previous proteomic studies of plasma EVs. This study shows that SEC alone is unable to completely separate plasma EVs from lipoprotein particles. However, combining SEC with a density cushion significantly improved the separation of EVs from lipoproteins and allowed for a detailed analysis of the proteome of plasma EVs, thus making blood a viable source for EV biomarker discovery. Electronic supplementary material The online version of this article (10.1007/s00018-018-2773-4) contains supplementary material, which is available to authorized users. INTRODUCTION A blood sample is minimally invasive and is one of the most commonly used samples for diagnostic purposes [1]. Diseased cells, such as tumour cells, and injured or stressed tissues release molecules into the bloodstream, and these molecules can be used to monitor the status of different tissues and organs without obtaining an invasive biopsy, and blood samples are, therefore, often referred to as a “liquid biopsy” [2]. Cells and molecules that can be analysed in a liquid biopsy include circulating tumour cells, cell-free DNA and RNA, soluble proteins, and extracellular vesicles (EVs) [2]. EVs are small (40–800 nm) membrane-enclosed vesicles that are released by all cells into the extracellular space [3, 4], and they contain RNA, lipids, proteins, and DNA that can be shuttled to other cells to influence the recipient cell’s phenotype [4–7]. Furthermore, patients suffering from diseases such as cancer have higher concentrations of circulating EVs, and these EVs can carry disease-specific molecules [3, 8–10]. Isolation of EVs from plasma and serum is, therefore, of great importance in the use of EVs as biomarkers for diseases such as cancer [3]. However, human plasma and serum contain a vast array of particles, including EVs, but also a dominating pool of lipid particles such as chylomicrons and multiple types of lipoprotein particles and plasma proteins, making blood one of the most difficult body fluids to isolate EVs from. Chylomicrons are produced after ingestion of fat-containing meals, and they transport lipids and cholesterol to the liver via the peripheral blood plasma. The size of chylomicrons varies with the amount of ingested fat, ranging from 75 to 1200 nm in diameter [11]. The liver transforms the fat in chylomicrons into very low-density lipoproteins (VLDL, 30–80 nm), which in turn can be converted into smaller types of lipoproteins (5–35 nm). These types include intermediate-density lipoprotein (IDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL), and all of these transport triglycerides and cholesterol to and from the peripheral tissues. Lipoprotein particles are very abundant in the circulation, and estimates have suggested that there are 20- to 100-fold more lipoproteins than EVs in isolates from plasma [12, 13], with chylomicrons further increasing in numbers after food intake [13]. In addition, it is suggested that > 70% of the particles isolated from plasma are non-EVs [14] and that EVs isolated from plasma are contaminated by HDL [12] and LDL [13]. Thus, a major hurdle in the characterisation of circulating EVs is that EVs are difficult to separate from lipoproteins and chylomicrons, not only because of these molecules’ abundance, but also because they resemble EVs in their physical features, including size and density. The aim of this study was, therefore, to develop a robust procedure for isolating EVs from human blood with minimal contamination of lipoprotein particles to enable the proteome of highly purified plasma EVs to be determined. MATERIALS AND METHODS Blood collection and processing Peripheral blood was collected from healthy donors after overnight-fasting. Briefly, for plasma, the blood was collected into K2E EDTA tubes, while for serum, the blood was collected into clot activator tubes. For plasma, processing was carried out directly, while, for serum, the sample was left at room temperature (RT) for 30 min to allow clotting. Plasma and serum were isolated by centrifugation at 1880×g for 10 min at RT. The plasma and serum were transferred to new tubes and centrifuged at 2500×g for 10 min at RT to minimise contamination by platelets. EVs were isolated directly by several different methods (Fig. 1). For some of the validating experiments, frozen plasma was used. Samples were collected with the approval of the Regional Ethical Approval Committee in Gothenburg, Sweden (no. 593-08).Fig. 1Schematic overview of the experimental workflow. Blood was collected in the morning from overnight-fasting healthy subjects, and plasma and serum were isolated. Several approaches were used to isolate EVs from plasma and serum and to separate them from lipoprotein particles and plasma proteins. HDL high-density lipoprotein, IDC iodixanol density cushion, RT room temperature, SEC size exclusion chromatography, UCF ultracentrifugation Isolation of EVs by size-exclusion chromatography EVs were isolated with an in-house made size-exclusion chromatography (SEC) column as previously described [15]. Briefly, Sepharose CL-2B (GE Healthcare, Uppsala, Sweden) was packed in a Telos SPE column (Kinesis, Cambridgeshire, UK) to a final volume of 10 mL and equilibrated with PBS. Fresh plasma or serum samples (1 mL) were applied to the premade column, and up to 30 fractions of 0.5 mL were collected with PBS as the elution buffer. Isolation of EVs by an iodixanol density cushion and size-exclusion chromatography An OptiPrep cushion was used for the removal of lipoprotein before loading the samples onto an SEC column. In brief, 6 mL of plasma was layered on top of a 2 mL 50%, 2 mL 30%, and 2 mL 10% OptiPrep cushion. The cushion and sample were centrifuged at 178,000×gavg (SW 41 Ti rotor, k-factor 143.9, Beckman Coulter, Brea, CA, USA) for 2 h at 4 °C. A visible band between the 10 and 30% layers was collected (high-density band) as well as a band that was floating on top of the plasma (low-density band) (Fig. 1). Collected bands were loaded onto separate SEC columns. If the collected bands were less than 1 mL in volume, PBS was added to a final volume of 1 mL prior to loading. For

Read the complete text